Key result
Treatment with doxorubicin and mitotane yielded no response in a patient with metastatic malignant Leydig cell tumor occurring 8 years after primary resection.
Population
1 patient with metastatic malignant Leydig cell tumor occurring 8 years after primary resection
Design
Case_report
Authors
Loading...
Supports chemoresistance to doxorubicin and mitotane in metastatic malignant Leydig cell tumors; leaves open effective systemic therapies.
Case Report (n=1)
Malignant Leydig cell tumors are highly resistant to chemotherapy, as demonstrated by a lack of response to doxorubicin and mitotane in this case.
Bertram et al. (1991) conducted a case report in Malignant Leydig cell tumor (n=1). Doxorubicin and mitotane was evaluated on Treatment response. Treatment with doxorubicin and mitotane yielded no response in a patient with metastatic malignant Leydig cell tumor occurring 8 years after primary resection.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: